Dante Labs Expands Its Full DNA Test With Proprietary Analysis of Mitochondrial and Neurological Diseases
NEW YORK, October 10, 2018 (Newswire.com) - Dante Labs is excited to announce the expansion of its existing full DNA Test with the analysis of Mitochondrial DNA (mtDNA), offering unparalleled insights for the analysis of Mitochondrial dysfunction & Neurological Disorders.
Dante Labs offers affordable technologically advanced DNA Tests for individuals and health care providers to garner insights into their health, lifestyle and risk for hereditary diseases on a non-invasive basis. The expansion of the full DNA testing to include mitochondrial analysis will provide consumers with an advanced ability to detect and identify a range of neurological diseases.
Mitochondrial DNA is passed down almost unchanged from a mother to her children. While Mitochondrial DNA is generally used to trace maternal ancestry, the medical applications can provide advancements for both analysis and diagnostics. The proprietary analysis of the Whole Genome and the Mitochondrial DNA together gives patients the maximum accuracy needed to specifically identify mitochondrial-dependent inherited genetic diseases such as; Diabetes mellitus and deafness (DAD), Leber’s Hereditary optic neuropathy (LHON), Leigh syndrome, Kearns-Sayre Syndrome, Pearson Syndrome, Mitochondrial encephalopathy, lactic acidosis and stroke-like episodes.
As new testing technologies and methodology continue to advance, we are integrating novel capabilities that can provide the highest levels of understanding. Mitochondrial DNA coupled with Whole Genome analysis may be the key to offering insights across neurological diseases.
“Dante Labs has always been committed to providing our customers and clients with the most robust ability to understand 100% of their DNA. As new testing technologies and methodology continue to advance these goals, we are integrating novel capabilities that can provide the highest levels of understanding. Mitochondrial DNA coupled with Whole Genome analysis may be the key to offering insights across neurological diseases.” Andrea Riposati, CEO of Dante Labs
ABOUT DANTE LABS:
Our mission is to make advanced genomic testing accessible to everyone. We want to empower people with knowledge and insights about their own genetic information so that they can live healthy, long and happy lives. We benefit from a full portfolio of sequencing platforms, from benchtop to factory-scale instruments that deliver the right level of speed, capacity and costs. www.Dantelabs.com
Source: Dante Labs